217 related articles for article (PubMed ID: 15288223)
1. Assessment of menstrual blood loss in women with ideopathic menorrhagia using the frameless levonorgestrel-releasing intrauterine system.
Wildemeersch D; Rowe PJ
Contraception; 2004 Aug; 70(2):165-8. PubMed ID: 15288223
[TBL] [Abstract][Full Text] [Related]
2. Treatment of menorrhagia with a novel 'frameless' intrauterine levonorgestrel-releasing drug delivery system: a pilot study.
Wildemeersch D; Schacht E
Eur J Contracept Reprod Health Care; 2001 Jun; 6(2):93-101. PubMed ID: 11518454
[TBL] [Abstract][Full Text] [Related]
3. Assessment of menstrual blood loss in Belgian users of a new T-shaped levonorgestrel-releasing intrauterine system.
Wildemeersch D; Rowe PJ
Contraception; 2005 Jun; 71(6):470-3. PubMed ID: 15914139
[TBL] [Abstract][Full Text] [Related]
4. Menstrual blood loss in women using the frameless FibroPlant LNG-IUS.
Andrade A; Wildemeersch D
Contraception; 2009 Feb; 79(2):134-8. PubMed ID: 19135571
[TBL] [Abstract][Full Text] [Related]
5. Assessment of menstrual blood loss in Brazilian users of the frameless copper-releasing IUD with copper surface area of 330 mm2 and the frameless levonorgestrel-releasing intrauterine system.
Andrade AT; Souza JP; Andrade GN; Rowe PJ; Wildemeersch D
Contraception; 2004 Aug; 70(2):173-7. PubMed ID: 15288225
[TBL] [Abstract][Full Text] [Related]
6. The effect on menstrual blood loss in women with uterine fibroids of a novel "frameless" intrauterine levonorgestrel-releasing drug delivery system: a pilot study.
Wildemeersch D; Schacht E
Eur J Obstet Gynecol Reprod Biol; 2002 Apr; 102(1):74-9. PubMed ID: 12039094
[TBL] [Abstract][Full Text] [Related]
7. Levonorgestrel-releasing intrauterine system for heavy menstrual bleeding improves hemoglobin and ferritin levels.
Kaunitz AM; Bissonnette F; Monteiro I; Lukkari-Lax E; DeSanctis Y; Jensen J
Contraception; 2012 Nov; 86(5):452-7. PubMed ID: 22959906
[TBL] [Abstract][Full Text] [Related]
8. Randomised comparative trial of the levonorgestrel intrauterine system and mefenamic acid for the treatment of idiopathic menorrhagia: a multiple analysis using total menstrual fluid loss, menstrual blood loss and pictorial blood loss assessment charts.
Reid PC; Virtanen-Kari S
BJOG; 2005 Aug; 112(8):1121-5. PubMed ID: 16045528
[TBL] [Abstract][Full Text] [Related]
9. Review of clinical experience with the frameless LNG-IUS for contraception and treatment of heavy menstrual bleeding.
Wildemeersch D; Andrade A
Gynecol Endocrinol; 2010 May; 26(5):383-9. PubMed ID: 20192899
[TBL] [Abstract][Full Text] [Related]
10. Contraception and treatment in the perimenopause with a novel "frameless" intrauterine levonorgestrel-releasing drug delivery system: an extended pilot study.
Wildemeersch D; Schacht E; Wildemeersch P
Contraception; 2002 Aug; 66(2):93-9. PubMed ID: 12204781
[TBL] [Abstract][Full Text] [Related]
11. A Canadian, multicentre study comparing the efficacy of a levonorgestrel-releasing intrauterine system to an oral contraceptive in women with idiopathic menorrhagia.
Endrikat J; Shapiro H; Lukkari-Lax E; Kunz M; Schmidt W; Fortier M
J Obstet Gynaecol Can; 2009 Apr; 31(4):340-347. PubMed ID: 19497153
[TBL] [Abstract][Full Text] [Related]
12. The levonorgestrel intrauterine system in the management of menorrhagia.
Barrington JW; Bowen-Simpkins P
Br J Obstet Gynaecol; 1997 May; 104(5):614-6. PubMed ID: 9166207
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic effects of the levonorgestrel-releasing intrauterine system in the treatment of idiopathic menorrhagia.
Xiao B; Wu SC; Chong J; Zeng T; Han LH; Luukkainen T
Fertil Steril; 2003 Apr; 79(4):963-9. PubMed ID: 12749438
[TBL] [Abstract][Full Text] [Related]
14. A randomized clinical trial of a levonorgestrel-releasing intrauterine system and a low-dose combined oral contraceptive for fibroid-related menorrhagia.
Sayed GH; Zakherah MS; El-Nashar SA; Shaaban MM
Int J Gynaecol Obstet; 2011 Feb; 112(2):126-30. PubMed ID: 21092958
[TBL] [Abstract][Full Text] [Related]
15. [The role of copper-releasing intrauterine device or levonorgestrel-releasing intrauterine system on uterine bleeding and iron status (prospective study of 8 years)].
Imperato F; Perniola G; Mossa B; Marziani R; Perniola F; Stragapede B; Napolitano C
Minerva Ginecol; 2002 Jun; 54(3):271-8. PubMed ID: 12063443
[TBL] [Abstract][Full Text] [Related]
16. Randomised comparative trial of the levonorgestrel intrauterine system and norethisterone for treatment of idiopathic menorrhagia.
Irvine GA; Campbell-Brown MB; Lumsden MA; Heikkilä A; Walker JJ; Cameron IT
Br J Obstet Gynaecol; 1998 Jun; 105(6):592-8. PubMed ID: 9647148
[TBL] [Abstract][Full Text] [Related]
17. The levonorgestrel-releasing intrauterine system provides a reliable, long-term treatment option for women with idiopathic menorrhagia.
Endrikat J; Vilos G; Muysers C; Fortier M; Solomayer E; Lukkari-Lax E
Arch Gynecol Obstet; 2012 Jan; 285(1):117-21. PubMed ID: 21475963
[TBL] [Abstract][Full Text] [Related]
18. Treatment of menorrhagia with an LNG-IUS.
Pakarinen P; Luukkainen T
Contraception; 2007 Jun; 75(6 Suppl):S118-22. PubMed ID: 17531601
[TBL] [Abstract][Full Text] [Related]
19. Mechanism of action of the levonorgestrel-releasing intrauterine system in the treatment of heavy menstrual bleeding.
Cihangir U; Ebru A; Murat E; Levent Y
Int J Gynaecol Obstet; 2013 Nov; 123(2):146-9. PubMed ID: 24028852
[TBL] [Abstract][Full Text] [Related]
20. Comparison of Therapeutic Efficacies of Norethisterone, Tranexamic Acid and Levonorgestrel-Releasing Intrauterine System for the Treatment of Heavy Menstrual Bleeding: A Randomized Controlled Study.
Kiseli M; Kayikcioglu F; Evliyaoglu O; Haberal A
Gynecol Obstet Invest; 2016; 81(5):447-53. PubMed ID: 26950475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
